Marine Drugs (Nov 2024)

Aeruginosin 525 (AER525) from Cyanobacterium <i>Aphanizomenon</i> Sp. (KUCC C2): A New Serine Proteases Inhibitor

  • Donata Overlingė,
  • Marta Cegłowska,
  • Robert Konkel,
  • Hanna Mazur-Marzec

DOI
https://doi.org/10.3390/md22110506
Journal volume & issue
Vol. 22, no. 11
p. 506

Abstract

Read online

Aeruginosins (AERs) are one of the most common classes of cyanobacterial peptides synthesised through a hybrid non-ribosomal peptide synthase/polyketide synthase pathway. They have been found in Microcystis, Nodularia spumigena, Oscillatoria/Plantothrix, and Nostoc. The presence of AER in Aphanizomenon isolated from the Curonian Lagoon was reported for the first time in our previous work. Here, the structure of aeruginosin 525 (AER525), isolated from Aphanizomenon sp. KUCC C2, was characterised based on high-resolution mass spectrometry. This new AER variant shows potent activity against thrombin. It also inhibits trypsin and carboxypeptidase A but has no effect on elastase and chymotrypsin. In terms of the N-terminal residue and biological activity, AER525 displaces some similarity to dysinosins, which belongs to the most potent inhibitors of thrombin among AERs. The findings underline the potential of AER525 as a new anticoagulant agent.

Keywords